Comparison of Frequency of Use of Optive and Systane

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00406510
Recruitment Status : Completed
First Posted : December 4, 2006
Last Update Posted : June 1, 2007
Information provided by:
Innovative Medical

Brief Summary:
The purpose of this study is subjectively compare duration of action between Optive and Systane.

Condition or disease Intervention/treatment Phase
Dry Eye Drug: Optive, Systane Phase 4

Study Type : Interventional  (Clinical Trial)
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single

Resource links provided by the National Library of Medicine

Drug Information available for: Systane
U.S. FDA Resources

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All

Inclusion Criteria:

  • Males or females > 18 years old
  • Mild to moderate dry eye symptoms
  • Score of at least 2 and no more than 4 on the SESOD at the initial screening visit
  • Likely to complete all study visits and able to provide informed consent

Exclusion Criteria:

  • Current use of topical cyclosporine
  • Known contraindications to any study medication or ingredients
  • Active ocular diseases or uncontrolled systemic disease (blepharitis patients that are actively being treated or disease that is uncontrollable)
  • Ocular surgery within the past 3 months,
  • Active ocular allergies

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00406510

United States, California
Private Practice
Azusa, California, United States, 91702
Sponsors and Collaborators
Innovative Medical
Principal Investigator: Milton Hom, OD Private Practice Identifier: NCT00406510     History of Changes
Other Study ID Numbers: 5283
First Posted: December 4, 2006    Key Record Dates
Last Update Posted: June 1, 2007
Last Verified: May 2007